Source:http://linkedlifedata.com/resource/pubmed/id/12120915
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-7-17
|
pubmed:abstractText |
Uncontrolled diabetes is associated with growth retardation. We investigated the effect of insulin-dependent diabetes on animal growth and IGF-I gene expression in the epiphyseal growth plate region of the long bones. We also studied the effect of GH administration on somatic growth in the diabetic state. Streptozotocin (STZ)-injected diabetic rats had a decreased somatic growth rate in comparison to controls. GH administration (2.5 U/kg day) in the diabetic animals (DGH group) prevented this decrease. Serum IGF-I levels were decreased in both diabetic and DGH animals. Within 72 h from diabetes onset, IGF-I mRNA levels in epiphyseal growth plate homogenates decreased whereas IGF-I receptor mRNA levels increased in diabetic animals. The decrease in IGF-I mRNA transcript levels was localized to the metaphyseal region by in situ hybridization. We conclude that in the STZ-induced diabetic state, the reduction in linear growth is associated with a parallel decrease in IGF-I gene expression at the epiphyseal growth plate area. Diabetic growth retardation can be reversed with GH administration, which does not reconstitute serum IGF-I levels. Therefore, we speculate that GH in this model may act locally through the skeletal GH-IGF-I system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Somatomedins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0940-5429
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12120915-Animals,
pubmed-meshheading:12120915-Blood,
pubmed-meshheading:12120915-Bone and Bones,
pubmed-meshheading:12120915-Diabetes Mellitus, Experimental,
pubmed-meshheading:12120915-Growth Disorders,
pubmed-meshheading:12120915-Growth Hormone,
pubmed-meshheading:12120915-Growth Plate,
pubmed-meshheading:12120915-Insulin-Like Growth Factor I,
pubmed-meshheading:12120915-Male,
pubmed-meshheading:12120915-RNA, Messenger,
pubmed-meshheading:12120915-Rats,
pubmed-meshheading:12120915-Rats, Sprague-Dawley,
pubmed-meshheading:12120915-Receptor, IGF Type 1,
pubmed-meshheading:12120915-Somatomedins
|
pubmed:year |
2002
|
pubmed:articleTitle |
Involvement of the skeletal GH-IGF system in an experimental model of diabetes-induced growth retardation.
|
pubmed:affiliation |
Department of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
|
pubmed:publicationType |
Journal Article
|